Larry Witte

Biochemistry, Genetics and Molecular Biology · Life Sciences

44h-index14.2kcitations95works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Angiogenesis and VEGF in Cancer(39), Monoclonal and Polyclonal Antibodies Research(25), Glycosylation and Glycoproteins Research(14), HER2/EGFR in Cancer Research(14), Cancer, Hypoxia, and Metabolism(10)

Publications95 total

Correction: Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human antihuman VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C
Journal of Cell Science·2023Open Access
Data from Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells
2023Open Access
Supplementary Data from Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells
2023Open Access
Data from Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells
2023Open Access
Supplementary Data from Anti–Transforming Growth Factor β Receptor II Antibody Has Therapeutic Efficacy against Primary Tumor Growth and Metastasis through Multieffects on Cancer, Stroma, and Immune Cells
2023Open Access
Data from Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth
2023Open Access
Supplementary Table 1 from Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth
2023Open Access
Supplementary Table 1 from Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth
2023Open Access
Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
2023Open Access
Supplementary Figure 1 from Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth
2023Open Access
Data from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
2023Open Access
Supplementary Figure 1 from Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth
2023Open Access
Supplementary Figures 1-9 from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
2023Open Access
Data from Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth
2023Open Access
Supplementary Figures 1-9 from Tumor Necrosis Factor-α and Interleukin-1 Antagonists Alleviate Inflammatory Skin Changes Associated with Epidermal Growth Factor Receptor Antibody Therapy in Mice
2023Open Access
Abstract 4997: Novel anti-PD-L1/IL-15 bifunctional immunotherapeutics potentiates antitumor immunity
Cancer Research·2016
Abstract 572: A novel anti-PDL1 x anti-VEGFR2 bispecific antibody for enhanced antitumor immunity
Cancer Research·2016
Abstract C173: Anti-PD-L1 antibody-based IL-15 immunocytokine has enhanced antitumor immunity
Molecular Cancer Therapeutics·2015· 1 cited
Abstract 2590: KD019: Blood brain barrier penetrant HER2/neu, Src, and EGFR inhibitor
Cancer Research·2015· 8 cited
Estimating preclinical efficacy targets utilizing cetuximab efficacy in KRAS mutant and wild-type colorectal cancer models.
PubMed·2011· 2 cited
page 1 of 5Next →

Frequent Co-authors

Zhenping Zhu(34), Daniel J. Hicklin(21), Peter Böhlen(19), Xenia Jimenez(14), Dale L. Ludwig(11), Shahin Rafii(10), Yan Wu(9), Rajiv Bassi(8), Paul Balderes(8), Sérgio Dias(7), Bronislaw Pytowski(7), Kris Persaud(7), Haifan Zhang(7), Malcolm A.S. Moore(6), Koichi Hattori(6), Beate Heissig(6), Helen Kotanides(6), Dan Lu(6), James R. Tonra(5), David Lyden(4)